Trending News
News
News
Making Pancreatic Tumors Visible to the Immune System
A new strategy has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.
News
"Worm-on-a-Chip" Device Could Help Diagnose Lung Cancer
Scientists report a device that uses tiny worms to detect lung cancer cells. This “worm-on-a-chip” could someday help doctors noninvasively diagnose cancer at an earlier stage.
News
World’s First PCR Test for Mouth Cancer Developed
The world's first PCR test that can diagnose mouth cancer from pre-malignant lesions has been developed, reducing the need for invasive biopsies.
News
Detailed Cell Atlas of the Fallopian Tube Created
Single-cell RNA sequencing of nearly 60,000 cells from the fallopian tube has enabled the development of a cell atlas that could pave the way for new research into infertility.
News
How Invading Cancer Cells Amass and Deploy Fuel to the “Front Line”
A study has shown how invading cancer cells amass and deploy fuel to the front lines of invasion to power their cellular break-through machinery.
News
Creating Tailored Cancer Vaccines With "Plug-and-Play" Tech
Scientists have created a pipeline for identifying, prioritizing and evaluating potential tumor antigens for the fast generation of cancer vaccines, according to research.
News
Screening Platform IDs 95% of Stage 1 Pancreatic Cancers
A new screening platform has flagged >95% of stage 1 pancreatic cancers, according to a pilot study published in Nature Communications Medicine.
News
Could Ketogenic Diet Boost Chemotherapy Efficacy?
A new study suggests that a ketogenic diet, low in carbohydrates and protein but high in fat, can help kill pancreatic cancer cells when combined with a triple-drug therapy.
News
Deep-Sea Microbe Provides Rich Source of Anticancer Molecule
Researchers have uncovered how a marine bacterium makes a potent anti-cancer molecule known as salinosporamide A.
News
Targeted Drug Boosts Survival in Early-Stage Breast Cancer With Inherited BRCA Mutations
A new clinical trial demonstrates that the drug olaparib improves survival in women with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.
Advertisement